HOME > VC DEALS > Colossal Biosciences
Deal IconDeal

Colossal Biosciences

Colossal Biosciences raises $120M Series C

Colossal Biosciences, a Dallas-based biotech startup focused on reviving extinct species, raised $120 million in a Series C fundraising round led by Peter Jackson, U.S. Innovative Technology Fund, and Bob Nelsen.

More on TechStartups →


ADVERTISEMENT carta_vcd_page_OCFO

Similar deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs